Literature DB >> 127645

H-rosette formation in T-cell-proliferative diseases.

P J Sheldon, E J Holborow.   

Abstract

In health up to 6% of human lymphocytes will form rosettes with homologous group O rhesus-negative erythrocytes (H rosettes). Increased numbers of H rosettes were found in T-cell-proliferative diseases-- namely, infectious mononucleosis, Sézary's syndrome, and T-cell leukaemia. H-rosette formation is thus a marker for a subpopulation of T lymphocytes, and this easily performed test of T-cell activation may have clinical value in characterising changes in blood lymphocyte populations in disease.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 127645      PMCID: PMC1675253          DOI: 10.1136/bmj.4.5993.381

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  25 in total

1.  Lymphocyte subpopulations. Human red blood cell rosettes.

Authors:  D Tak Yan Yu
Journal:  Clin Exp Immunol       Date:  1975-05       Impact factor: 4.330

Review 2.  Phytohemagglutin and concanavalin A: probes for murine 'T' cell activivation and differentiation.

Authors:  J D Stobo
Journal:  Transplant Rev       Date:  1972

3.  Thymus-derived proliferating lymphocytes in chronic lymphocytic leukaemia.

Authors:  I Lille; A Desplaces; L Meeus; R T Saracino; J C Brouet
Journal:  Lancet       Date:  1973-08-04       Impact factor: 79.321

4.  Thymic origin of atypical lymphoid cells in infectious mononucleosis.

Authors:  P J Sheldon; E H Hemsted; M Papamichail; E J Holborow
Journal:  Lancet       Date:  1973-05-26       Impact factor: 79.321

5.  Characterisation of malignant mediastinal lymphoid neoplasm (Sternberg sarcoma) as thymic in origin.

Authors:  J L Smith; G P Clein; C R Barker; R D Collins
Journal:  Lancet       Date:  1973-01-13       Impact factor: 79.321

6.  Immunoglobulins on the surface of human lymphocytes.

Authors:  M Papamichail; J C Brown; E J Holborow
Journal:  Lancet       Date:  1971-10-16       Impact factor: 79.321

7.  Identification of human T and B lymphocytes in normal peripheral blood and in chronic lymphocytic leukaemia.

Authors:  J D Wilson; G J Nossal
Journal:  Lancet       Date:  1971-10-09       Impact factor: 79.321

8.  Cell surface localized IgM-kappa immunoglobulin reactivity in a case of chronic lymphocytic leukaemia.

Authors:  B Johansson; E Klein
Journal:  Clin Exp Immunol       Date:  1970-03       Impact factor: 4.330

9.  Human T lymphocytes form rosettes with autologous and allogeneic human red blood cells.

Authors:  J Kaplan
Journal:  Clin Immunol Immunopathol       Date:  1975-03

10.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

View more
  5 in total

1.  Evidence for the presence of a receptor for IgM on the pathological cells of Sézary's syndrome.

Authors:  C P Worman; G F Burns; C R Barker
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

2.  A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias.

Authors:  R J Lukes; C R Taylor; J W Parker; T L Lincoln; P K Pattengale; B H Tindle
Journal:  Am J Pathol       Date:  1978-02       Impact factor: 4.307

3.  Reduction in peripheral blood K cells and activated T cells in primary biliary cirrhosis.

Authors:  G P Sandilands; R N Macsween; K G Gray; R J Holden; P Mills; F M Reid; M A Thomas; G Watkinson
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

4.  Lymphocyte populations in liver biopsy specimens from patients with chronic liver disease.

Authors:  J Sanchez-Tapias; H C Thomas; S Sherlock
Journal:  Gut       Date:  1977-06       Impact factor: 23.059

5.  Electrophoretic behaviour of blood and synovial fluid lymphocytes in rheumatoid arthritis.

Authors:  K A Brown; P H Embling; J D Perry; E J Holborow
Journal:  Clin Exp Immunol       Date:  1979-05       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.